CD8A and primary biliary cholangitis: The dnTGFβRII (TG) mice is a well-established murine model of human PBC with transgenic expression of a dominant negative form of human TGF-β receptor type II under the control of the mouse CD4 promoter, which leads to the blockade of TGFβ signaling pathway in CD4+ T and CD8+ T cells (15).